RxDoctor Payments Data

Maria Cupp

Physician Assistant · Traverse City, MINPI 1558647354

Payments from drug & device makers

$3,740in general payments, 2019–2025

Across 157 payments — averaging $23.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$595
  • GSK$428
  • Novo Nordisk$368
  • AstraZeneca$352
  • Boehringer Ingelheim$205
  • Johnson & Johnson$189
  • plus $2K from 22 others

What the payments were for

  • Food & beverage$3,740100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,740 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter81$85,560
EliquisApixaban59$74,205
JardianceEmpagliflozin56$59,410
OzempicSemaglutide47$58,223
TrulicityDulaglutide26$35,715
XareltoRivaroxaban33$34,992
MounjaroTirzepatide20$24,547
FarxigaDapagliflozin Propanediol15$24,138
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$6,902
Praluent PenAlirocumab11$4,914
Albuterol Sulfate HfaAlbuterol Sulfate91$3,411
Atorvastatin Calcium261$3,395
Levothyroxine Sodium232$2,893
Omeprazole167$2,703
Potassium Chloride82$2,331

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta$428$92,46394 claims
PfizerEliquis$49$74,20559 claims
Lilly USA, LLCTrulicity, Mounjaro$123$60,26246 claims
Boehringer IngelheimJardiance$205$59,41056 claims
Novo NordiskOzempic$368$58,22347 claims
Johnson & JohnsonXarelto$189$34,99233 claims
AstraZenecaFarxiga$352$24,13815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Traverse City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →